Biodexa pharmaceuticals launches new corporate and clinical trials websites

Biodexa pharmaceuticals launches new corporate and clinical trials websites biodexa pharmaceuticals plc (nasdaq: bdrx) (“biodexa” or the “company”),  a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain is pleased to announce that it has launched its new corporate website at www.biodexapharma.com as well as a patient focused website aimed at providing patients information about the therapeutic areas biodexa is studying in it's ongoing clinical programmes: www.resolvetrials.org . new corporate website our new website reflects the company's evolution from a drug delivery technology organisation to a drug development company focused on rare / orphan diseases and oncology with a mission to advance the development of medicines that offer patients a better future.
BDRX Ratings Summary
BDRX Quant Ranking